Literature DB >> 24214094

The critical level of cadmium in renal cortex: the concept and its limitations.

E C Foulkes1.   

Abstract

Because renal cortex is a primary target organ of Cd the seriousness of human exposure is commonly assessed in terms of the extent to which it permits renal cortical Cd concentrations to approach a critical value. The critical value has been defined in terms of PCC-10, the population critical concentration at which 10% of exposed individuals may be expected to show abnormal renal function. In chronically exposed human populations, PCC-10 appears to lie in the range of 180 to 220 μg Cd/gram fresh weight of cortex. However, Cd accumulated in the kidney under these conditions is distributed between more than one compartment, in all likelihood differing greatly in their toxicological characteristics. For instance, a major fraction of this Cd is bound to metallothionein, and may as such be relatively inert. Compartmentation of tissue Cd, in turn, is strongly influenced by the nature of exposure, and the PCC-10 value of 200 μg/g may therefore have limited general significance. The problem of risk assessment is further complicated by the high variability of Cd absorption. Nevertheless, human renal Cd levels commonly reach values as high as 1/3 to 1/6 of the chronic PCC-10, and further increases in Cd intake should therefore be avoided.

Entities:  

Year:  1986        PMID: 24214094     DOI: 10.1007/BF02439209

Source DB:  PubMed          Journal:  Environ Geochem Health        ISSN: 0269-4042            Impact factor:   4.609


  14 in total

1.  Variation of cadmium concentration in Swedish wheat and barley. An indicator of changes in daily cadmium intake during the 20th century.

Authors:  T Kjellström; L Linnman
Journal:  Arch Environ Health       Date:  1975-07

2.  Does a critical concentration of cadmium in human renal cortex exist.

Authors:  K Nomiyama
Journal:  J Toxicol Environ Health       Date:  1977-10

3.  A mathematical model for deriving the biological half-life of a chemical.

Authors:  K Tsuchiya; M Sugita
Journal:  Nord Hyg Tidskr       Date:  1971

4.  Conceptual problems in establishing the critical concentration of cadmium in human kidney cortex.

Authors:  T Kjellström; C G Elinder; L Friberg
Journal:  Environ Res       Date:  1984-04       Impact factor: 6.498

5.  In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine.

Authors:  H A Roels; R R Lauwerys; J P Buchet; A Bernard; D R Chettle; T C Harvey; I K Al-Haddad
Journal:  Environ Res       Date:  1981-10       Impact factor: 6.498

6.  Histopathological changes in relation to cadmium concentration in horse kidneys.

Authors:  C G Elinder; L Jönsson; M Piscator; B Rahnster
Journal:  Environ Res       Date:  1981-10       Impact factor: 6.498

7.  Cadmium found in non-soluble fraction of kidney homogenates and its relation to renal dysfunction after cadmium-cysteine administration.

Authors:  T Maitani; Y Saito; K T Suzuki
Journal:  Toxicology       Date:  1985-10       Impact factor: 4.221

8.  The critical level of cadmium in human renal cortex: a reevaluation.

Authors:  H Roels; R Lauwerys; A N Dardenne
Journal:  Toxicol Lett       Date:  1983-03       Impact factor: 4.372

9.  The chemical form of cadmium in microsomal and mitochondrial fractions from rat liver and kidney after long term administration of cadmium chloride.

Authors:  H Nakazawa; Y Masuzawa; K Waku
Journal:  Toxicol Lett       Date:  1981-02       Impact factor: 4.372

10.  Kinetics of renal aspartate reabsorption and its inhibition by metals in the intact rat kidney.

Authors:  G Linder; E C Foulkes
Journal:  Environ Res       Date:  1985-02       Impact factor: 6.498

View more
  1 in total

1.  Chronic low-level cadmium exposure in rats affects cytokine production by activated T cells.

Authors:  Alexandra E Turley; Joseph W Zagorski; Rebekah C Kennedy; Robert A Freeborn; Jenna K Bursley; Joshua R Edwards; Cheryl E Rockwell
Journal:  Toxicol Res (Camb)       Date:  2019-01-04       Impact factor: 3.524

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.